Alfacell’s Onconase shows promise as radiation sensitizer for lung cancer treatment
October 30th, 2007
Co announces that Intae Lee with the University of Pennsylvania has reported that Alfacell’s Onconase could be a promising radiation sensitizer for lung cancer treatment. Lee presented the pre- clinical in vivo data at the American Society for Therapeutic Radiology and Oncology 49th Annual Meeting. Lee provided pre-clinical evidence that Onconase significantly increased the radiation-induced tumor growth delay of lung tumors in vivo without increases in skin reaction compared to radiation alone.